BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31896576)

  • 1. Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.
    Nigam AK; Li JG; Lall K; Shi D; Bush KT; Bhatnagar V; Abagyan R; Nigam SK
    J Biol Chem; 2020 Feb; 295(7):1829-1842. PubMed ID: 31896576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.
    Bush KT; Wu W; Lun C; Nigam SK
    J Biol Chem; 2017 Sep; 292(38):15789-15803. PubMed ID: 28765282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3.
    Granados JC; Richelle A; Gutierrez JM; Zhang P; Zhang X; Bhatnagar V; Lewis NE; Nigam SK
    J Biol Chem; 2021; 296():100575. PubMed ID: 33757768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.
    Wu W; Bush KT; Nigam SK
    Sci Rep; 2017 Jul; 7(1):4939. PubMed ID: 28694431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue.
    Nagle MA; Wu W; Eraly SA; Nigam SK
    Neurosci Lett; 2013 Feb; 534():133-8. PubMed ID: 23196129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways.
    Wu W; Jamshidi N; Eraly SA; Liu HC; Bush KT; Palsson BO; Nigam SK
    Drug Metab Dispos; 2013 Oct; 41(10):1825-34. PubMed ID: 23920220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach.
    Liu HC; Goldenberg A; Chen Y; Lun C; Wu W; Bush KT; Balac N; Rodriguez P; Abagyan R; Nigam SK
    J Pharmacol Exp Ther; 2016 Oct; 359(1):215-29. PubMed ID: 27488918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of Organic Anion Transport in Humans After Treatment With the Drug Probenecid Leads to Major Metabolic Alterations in Plasma and Urine.
    Granados JC; Bhatnagar V; Nigam SK
    Clin Pharmacol Ther; 2022 Sep; 112(3):653-664. PubMed ID: 35490380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A key role for the transporter OAT1 in systemic lipid metabolism.
    Granados JC; Nigam AK; Bush KT; Jamshidi N; Nigam SK
    J Biol Chem; 2021; 296():100603. PubMed ID: 33785360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.
    Bush KT; Singh P; Nigam SK
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity.
    Bam RA; Yant SR; Cihlar T
    Antivir Ther; 2014; 19(7):687-92. PubMed ID: 24699134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.
    Truong DM; Kaler G; Khandelwal A; Swaan PW; Nigam SK
    J Biol Chem; 2008 Mar; 283(13):8654-63. PubMed ID: 18174163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.
    Nagle MA; Truong DM; Dnyanmote AV; Ahn SY; Eraly SA; Wu W; Nigam SK
    J Biol Chem; 2011 Jan; 286(1):243-51. PubMed ID: 20921221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions.
    Jamshidi N; Nigam SK
    Sci Rep; 2022 Oct; 12(1):18308. PubMed ID: 36316339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
    El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
    Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
    Zhang Z; Tachikawa M; Uchida Y; Terasaki T
    Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters.
    Wong CC; Barron D; Orfila C; Dionisi F; Krajcsi P; Williamson G
    Mol Nutr Food Res; 2011 Jul; 55(7):979-88. PubMed ID: 21538853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of organic cations with organic anion transporters.
    Ahn SY; Eraly SA; Tsigelny I; Nigam SK
    J Biol Chem; 2009 Nov; 284(45):31422-30. PubMed ID: 19737926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
    Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
    Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.
    Vallon V; Eraly SA; Rao SR; Gerasimova M; Rose M; Nagle M; Anzai N; Smith T; Sharma K; Nigam SK; Rieg T
    Am J Physiol Renal Physiol; 2012 May; 302(10):F1293-9. PubMed ID: 22338083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.